Evaluation of 18F-FAPI-42-RGD as a novel dual-targeting PET tracer in gastric cancer xenograft models
American Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.62347/gtzz9726 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Yongsheng Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
- Department of Nuclear Medicine, Peking University Shenzhen Hospital Shenzhen, Guangdong, China.
- Department of Pharmacy, Peking University Shenzhen Hospital Shenzhen, Guangdong, China.
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
Zitieren
APA
Zhao, Y., Li, J., Chen, P., Li, Z., & Yu, Y. (2025). Evaluation of 18F-FAPI-42-RGD as a novel dual-targeting PET tracer in gastric cancer xenograft models. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/gtzz9726
Vancouver
Zhao Y, Li J, Chen P, Li Z, Yu Y. Evaluation of 18F-FAPI-42-RGD as a novel dual-targeting PET tracer in gastric cancer xenograft models. American Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.62347/gtzz9726
BibTeX
@article{Zhao2025,
author = {Zhao, Yongsheng and Li, Jun and Chen, Ping and Li, Zhan and Yu, Yongqiang},
title = {Evaluation of 18F-FAPI-42-RGD as a novel dual-targeting PET tracer in gastric cancer xenograft models},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.62347/gtzz9726}
}
EUVIMED